SAWAF AZIZ (SVP & CHIEF FINANCIAL OFFICER) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/24/2025ACC: 0001415889-25-005353
Officer· SVP & CHIEF FINANCIAL OFFICER
Since Feb 2026
-13.75K
Net shares
Net seller
$132.8K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
13.75K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−13.75K
Price / share
$9.66
Trade value
$132.83K
% of position
4.4%
2/20/2025
312.89K→299.14K
Total
Net shares
−13.75K
Net value
-$132.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/20/2025 | F · Tax Withholding | −13.75K | $9.66 | $132.83K | 4.4% | 312.89K | 299.14K |
| Total | −13.75K | -$132.83K | ||||||
Derivative Transactions0
No derivative transactions reported